Jacob Rong Bentsen, Torbjørn Lien Kjær, Magnus Roland Balleby, Jimmi Nielsen
{"title":"Use of Testosterone-Lowering Medication in Patients With Intellectual Disabilities and Problematic Sexual Behaviour: A Case Series.","authors":"Jacob Rong Bentsen, Torbjørn Lien Kjær, Magnus Roland Balleby, Jimmi Nielsen","doi":"10.1155/crps/6191292","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Testosterone-lowering medication (TLM) is used in severe cases of paraphilic disorders and problematic sexual behaviour, but its use in patients with intellectual disability is not well characterised.</p><p><strong>Method: </strong>A nationwide survey identified five male patients with intellectual disability who had received TLM in specialised outpatient clinics.</p><p><strong>Results: </strong>Four patients showed reduced problematic sexual behaviour during treatment; three relapsed after discontinuation. Adverse effects included osteoporosis, hypertension, depression and suppressed sexual development. Monitoring and access varied regionally.</p><p><strong>Conclusions: </strong>TLM may be effective in selected patients with intellectual disability but requires careful monitoring and ethical oversight.</p>","PeriodicalId":9631,"journal":{"name":"Case Reports in Psychiatry","volume":"2026 ","pages":"6191292"},"PeriodicalIF":0.0000,"publicationDate":"2026-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13238502/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Psychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/crps/6191292","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Testosterone-lowering medication (TLM) is used in severe cases of paraphilic disorders and problematic sexual behaviour, but its use in patients with intellectual disability is not well characterised.
Method: A nationwide survey identified five male patients with intellectual disability who had received TLM in specialised outpatient clinics.
Results: Four patients showed reduced problematic sexual behaviour during treatment; three relapsed after discontinuation. Adverse effects included osteoporosis, hypertension, depression and suppressed sexual development. Monitoring and access varied regionally.
Conclusions: TLM may be effective in selected patients with intellectual disability but requires careful monitoring and ethical oversight.